West Bengal CM Suvendu Adhikari Eats Traditional Fish Bhog at Kolkata's Kalighat Temple

Goa, Sept. 12 -- West Bengal Chief Minister Suvendu Adhikari's visit to Kolkata's centuries-old Kalighat Temple has drawn attention after he was seen partaking in the traditional non-vegetarian bhog s... Read More

Khalid Maqbool calls for provinces based on populationPublished on: September 12, 2026 10:07 PM

Pakistan, Sept. 12 -- Muttahida Qaumi Movement Pakistan Chairman Khalid Maqbool Siddiqui has called for provinces based on population across Pakistan. He made the remarks while addressing an event in ... Read More

Pay compensation for school takeover or lose it, court tells Akwa Ibom govt

Nigeria, Sept. 12 -- An Akwa Ibom State High Court in Uyo has given the state government three months to "assess and pay adequate compensation" for taking over a private school or return it to its ori... Read More

Assam conservationist urges SC panel to halt transfer of 5 elephants to Tamil Nadu

Guwahati, Sept. 12 -- Assam conservationist Rohit Choudhury has urged the Supreme Court-appointed High Powered Committee (HPC) to immediately intervene and halt the ongoing transfer of four captive el... Read More

Bigg Boss 20: Big update on first week elimination, who is out?

Mumbai, Sept. 12 -- Bigg Boss 20 is ready for its first Weekend Ka Vaar, with Kanika Mann, Uditi Singh, Arishfa Khan and Love Gill currently facing the threat of eviction. But who will become the firs... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib ... Read More

Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pemb... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eva... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety an... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety an... Read More

• ««
• «
• 2563
• 2564
• 2565
• 2566
• 2567
• 2568
• 2569
• 2570
• 2571
• 2572
• »
• »»